U.S. markets closed
  • S&P 500

    3,811.15
    -18.19 (-0.48%)
     
  • Dow 30

    30,932.37
    -469.64 (-1.50%)
     
  • Nasdaq

    13,192.35
    +72.92 (+0.56%)
     
  • Russell 2000

    2,201.05
    +0.88 (+0.04%)
     
  • Crude Oil

    61.66
    -1.87 (-2.94%)
     
  • Gold

    1,733.00
    -42.40 (-2.39%)
     
  • Silver

    26.70
    -0.98 (-3.56%)
     
  • EUR/USD

    1.2088
    -0.0099 (-0.81%)
     
  • 10-Yr Bond

    1.4600
    -0.0580 (-3.82%)
     
  • GBP/USD

    1.3921
    -0.0091 (-0.65%)
     
  • USD/JPY

    106.5500
    +0.3200 (+0.30%)
     
  • BTC-USD

    47,014.92
    +182.75 (+0.39%)
     
  • CMC Crypto 200

    912.88
    -20.25 (-2.17%)
     
  • FTSE 100

    6,483.43
    -168.53 (-2.53%)
     
  • Nikkei 225

    28,966.01
    -1,202.26 (-3.99%)
     

Chemours: 4Q Earnings Snapshot

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.

WILMINGTON, Del. (AP) _ Chemours Co. (CC) on Thursday reported fourth-quarter net income of $19 million, after reporting a loss in the same period a year earlier.

The Wilmington, Delaware-based company said it had profit of 11 cents per share. Earnings, adjusted for non-recurring costs, came to 61 cents per share.

The results topped Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of 36 cents per share.

The chemical company posted revenue of $1.3 billion in the period.

For the year, the company reported net income of $219 million, or $1.32 per share, swinging to a profit in the period. Revenue was reported as $4.97 billion.

Chemours expects full-year earnings in the range of $2.40 to $3.12 per share.

Chemours shares have climbed 11% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $27.42, a rise of 84% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CC at https://www.zacks.com/ap/CC